AU2001256334A1 - Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs - Google Patents

Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs

Info

Publication number
AU2001256334A1
AU2001256334A1 AU2001256334A AU5633401A AU2001256334A1 AU 2001256334 A1 AU2001256334 A1 AU 2001256334A1 AU 2001256334 A AU2001256334 A AU 2001256334A AU 5633401 A AU5633401 A AU 5633401A AU 2001256334 A1 AU2001256334 A1 AU 2001256334A1
Authority
AU
Australia
Prior art keywords
omega
acids
clinical signs
conjugated linoleic
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001256334A
Inventor
Klaus Sommermeyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi Deutschland GmbH
Original Assignee
Fresenius Kabi Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7640945&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001256334(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi Deutschland GmbH filed Critical Fresenius Kabi Deutschland GmbH
Publication of AU2001256334A1 publication Critical patent/AU2001256334A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Abstract

The invention relates to the combined use of omega -3-fatty acids and/or their derivatives and of conjugated linoleic acids (CLA) and/or derivatives thereof for producing a preparation for use against clinical signs with pronounced immunological components.
AU2001256334A 2000-05-05 2001-05-03 Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs Abandoned AU2001256334A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10022001 2000-05-05
DE10022001 2000-05-05
PCT/EP2001/005011 WO2001085161A1 (en) 2000-05-05 2001-05-03 Combination preparation consisting of φ-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs

Publications (1)

Publication Number Publication Date
AU2001256334A1 true AU2001256334A1 (en) 2001-11-20

Family

ID=7640945

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001256334A Abandoned AU2001256334A1 (en) 2000-05-05 2001-05-03 Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs

Country Status (7)

Country Link
EP (1) EP1296669B1 (en)
AT (1) ATE312604T1 (en)
AU (1) AU2001256334A1 (en)
DE (1) DE50108392D1 (en)
DK (1) DK1296669T3 (en)
ES (1) ES2250397T3 (en)
WO (1) WO2001085161A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10329839A1 (en) * 2003-06-04 2005-01-05 Hogl, Peter Use of artificial nutrition solutions to treat skin diseases, especially psoriasis, neurodermatitis, acne, dermatoses or eczema
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2107663T3 (en) * 1992-04-28 1997-12-01 Fresenius Ag USE OF AN EMULSION CONTAINING OMEGA-3 FATTY ACIDS IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO BE ADMINISTERED BY THE PARENTERAL WAY FOR THE TREATMENT OF INFLAMMATORY DISEASES.
DE4432633C2 (en) * 1994-09-14 1997-07-31 Singer Peter Dr Med Priv Doz Pharmaceutical preparation for the local treatment of psoriasis, atopic dermatitis and eczema
GB9621630D0 (en) * 1996-10-17 1996-12-11 Kappa Pharmaceuticals Ltd Treatment of skin disorders
NZ503398A (en) * 1997-08-18 2002-06-28 Univ South Dakota Dairy products with enhanced conjugated linoleic acid content derived from milk of ruminants fed with fish oil

Also Published As

Publication number Publication date
WO2001085161A1 (en) 2001-11-15
EP1296669A1 (en) 2003-04-02
EP1296669B1 (en) 2005-12-14
DE50108392D1 (en) 2006-01-19
ATE312604T1 (en) 2005-12-15
ES2250397T3 (en) 2006-04-16
DK1296669T3 (en) 2006-04-18

Similar Documents

Publication Publication Date Title
AU658619B2 (en) Benzopyranones, methods of manufacture and use thereof
BG103335A (en) Application of fumaric acid derivatives
DE69727138D1 (en) DIETETIC BABY FOOD WITH CONJUGATED LINOLIC ACIDS
WO2003011873A3 (en) Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
AU2001252638A1 (en) Process for the preparation of 2-halobenzoic acids
WO2000067801A3 (en) Prodrugs of chemotherapeutic agents with oxaalkanoic acids
WO2002043685A3 (en) Cosmetic and/or pharmaceutical emulsions
AU1277397A (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU2732597A (en) Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
HU9602740D0 (en) Halofanthine free base for the treatment of malaria and compositions
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU2001265186A1 (en) Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions
BG102770A (en) New derivatives of carboxylic acids, their preparation and application
AU2001274526A1 (en) Remedies for allergic diseases and process for producing the same
HUP0202729A2 (en) Compositions for parenteral use of estramustine phosphate and amino acids
AU2003204353A1 (en) Methods and compositions for enhancing immune response and for the production of in vitro mabs
AU2001256334A1 (en) Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs
AU2003257084A1 (en) Novel anticancer conjugates of camptothecin and unsaturated fatty acids
WO2002087535A3 (en) Use of esterquats
AUPQ480399A0 (en) Unsaturated fatty acids and their uses in therapy
AUPQ866500A0 (en) Therapeutic compounds and methods
UA42797C2 (en) Quinolone- and naphthyridonecarboxylic acid derivatives and isoindole derivatives for preparation thereof
WO1998038994A3 (en) Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
AU2002218494A1 (en) Medicinal compositions and process for producing the same